Mltidisciplinary Masterclass dedicated to prostate and bladder cancers

News
Mltidisciplinary Masterclass dedicated to prostate and bladder cancers
Share this page
Mltidisciplinary Masterclass dedicated to prostate and bladder cancers
Texte

On the occasion of the multidisciplinary Masterclass organized by the American Hospital in Paris, MEDIPATH and Ibex Medical Analytics dedicated to prostate and bladder cancers, Camelia Radulescu, anatomopathologist at the Foch Hospital, presented the article: Radulescu et al. Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test - published in 2021 in the British Journal of Urology (BJUI).

This article presents the results of the phase 1 of our multicenter clinical study VISIOCYT 1, which involved 14 renowned French centers and demonstrated the superiority of the VisioCyt® test over conventional urinary cytology.

Translated with www.DeepL.com/Translator (free version)


Previous
Next